Researchers have demonstrated that the type of bacteria living in the gut can influence the development of Alzheimer's disease symptoms in mice. The study shows that, by altering the gut microbiome, long-term antibiotic treatment reduces inflammation and slows the growth of amyloid plaques in the brains of male mice, though the same treatment has no effect on female animals.